Verley vs Bactolife
Side-by-side comparison of AI visibility scores, market position, and capabilities
Raised $38M Series A (Feb 2026). First global FDA clearance for functionalized dairy proteins via precision fermentation. 81% less water, 99% less land than conventional dairy.
About
Verley is a precision fermentation company that received the world's first FDA "No Questions" clearance for functionalized dairy whey proteins produced through microbial fermentation rather than conventional dairy production. The company raised $38 million in Series A financing in February 2026, with commercial FermWhey ingredient sales planned to US food manufacturers by end-2026.
Raised €30M+ Series B (Jan 2026) with Gates Foundation as cornerstone investor. Novel Binding Proteins (Helm brand) for gut health launching in US in 2026.
About
Bactolife is a Danish precision fermentation company developing Binding Proteins — a novel functional protein category inspired by camelid immunoglobulins (nanobodies) and produced through microbial fermentation. Marketed under the Helm brand, these proteins are designed to support gut health by binding to harmful pathogens and inflammatory triggers in the digestive system. The company raised €30 million+ in Series B financing in January 2026, co-led by Cross Border Impact Ventures and the Danish Green Future Fund, with the Gates Foundation as a cornerstone investor.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.